Celltrion chairman\

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Asset management Mirae Asset bets on China as Korean investors’ US focus draws concern

South Korea’s leading asset manager Mirae Asset Financial Group is increasingly unveiling China-focused investment products as Chairman P...

Bio & Pharma Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Korean chipmakers SK chairman in Taiwan to deepen ties with TSMC

Chey Tae-won, chairman of SK Group, the parent of SK Hynix Inc., is visiting Taiwan amid the threat of escalating US tariff threats, suggesting the ...

Bio & Pharma Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Mergers & Acquisitions Korea Zinc faces multiple legal, regulatory challenges in fight against MBK

Korea Zinc Inc. Chairman Choi Yun-birm appears to have kept his grip on the world’s largest zinc smelter after successfully fending off an MBK...

Private equity MBK sees better exit landscape in 2025, bets on governance reform

MBK Partners sees a recovery in the exit environment in 2025 and seeks to capitalize on the opportunities emerging from corporate governance reform ...

Leadership & Management Hanwha gears up for 3rd-generation leadership with chairman’s stake gift

South Korea’s chemical-to-defense conglomerate Hanwha Group Chairman Kim Seung-youn will hand over half of his holdings in the conglomerate&rs...

Bio & Pharma Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

Leadership & Management Samsung Chairman Lee meets with Xiaomi CEO Lei Jun for partnership

BEIJING – Samsung Electronics Co. Chairman Lee Jae-yong has met with Xiaomi Inc. Chief Executive Lei Jun in the Chinese capital, raising specu...

Debt financing MBK chairman to leverage own funds to pay Homeplus suppliers

Michael ByungJu Kim, the co-founder, partner and chairman of Northeast Asia-focused private equity firm (PEF) MBK Partners Ltd., is expected to leve...

Shareholder value Celltrion to cancel $140 mn in treasury shares, stock up

South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...

Bio & Pharma Samsung, Celltrion lead biosimilar market in Europe, US

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Private equity Affinity, GIC sell out of Kyobo Life; Chairman Shin seeks holding firm, M&A

Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...

Private equity MBK commits to restoring Homeplus operations: MBK Vice Chairman Kim

MBK Partners, facing increasing scrutiny over its highly leveraged acquisition of Homeplus Co., has pledged to go all-out to restore the struggling ...

Electronics LG Group chair visits India ahead of LG Electronics Indian IPO

LG Group Chairman Koo Kwang-mo visited LG Electronics Inc.'s factory and research center in India in late February as it plans to list its Indian ar...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Leadership & Management Mirae Asset prepares bitcoin covered call ETF launch: chairman

Mirae Asset Financial Group is preparing to launch a bitcoin covered call exchange traded fund (ETF) for global investors to foray into the cryptocu...

Artificial intelligence LG, SNU team up to develop AI modeling for protein structure predictions

LG AI Research Institute, the artificial intelligence think-tank of LG Group, South Korea’s fourth-biggest conglomerate, on Thursday signed a ...

Bio & Pharma Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Leadership & Management Samsung set to rebuild with leader Lee cleared of all charges

Samsung Electronics Co. Chairman Lee Jae-yong was found not guilty of accounting fraud, stock manipulation and other criminal charges by a Seoul app...

Shipping & Shipbuilding HD KSOE wins $2.6 bn order for 12 container ships

South Korea’s largest shipbuilder HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE) said on Thursday it got 3.716 trillion won ...

IPOs Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

Korean Innovators at CES 2025 SK Hynix to collaborate with Nvidia on Cosmos physical AI platform: Chey

LAS VEGAS – SK Hynix Inc., the world’s second-largest memory chipmaker, has agreed to collaborate with Nvidia Corp. on the top US AI chi...

Mergers & Acquisitions Korea Zinc chair reported to prosecutors over rights issue

South Korea’s Financial Supervisory Service (FSS) has reported Korea Zinc Inc.'s Chairman Choi Yun-birm and its board of directors to prosecut...

Bio & Pharma Korean drugmakers control more than half of European biosimilar market

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

Corporate governance Hanmi Pharm’s chair poised to win management feud with her son

Hanmi Pharmaceutical Group Chairman Song Young-sook is poised to claim victory in a year-long dispute with her eldest son Lim Jong-yoon to take cont...

Business & Politics Korea’s Shinsegae chairman dines with Trump at Mar-a-Lago

Chung Yong-jin, the chairman of South Korea’s retail giant Shinsegae Group, held talks with US President-elect Donald Trump, becoming Korea's ...

Bio & Pharma Celltrion obtains approval of Steqeyma from FDA

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Bio & Pharma Celltrion BioSolutions launched to venture into CDMO

Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...